Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Other financing activities: 2019-2025

  • Benitec Biopharma's Other financing activities fell 97.54% to $72,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $5.2 million, marking a year-over-year decrease of 43.86%. This contributed to the annual value of $2.3 million for FY2025, which is 60.64% down from last year.
  • As of Q2 2025, Benitec Biopharma's Other financing activities stood at $72,000, which was down 96.79% from $2.2 million recorded in Q1 2025.
  • In the past 5 years, Benitec Biopharma's Other financing activities registered a high of $3.0 million during Q3 2023, and its lowest value of $2,000 during Q4 2024.
  • Moreover, its 3-year median value for Other financing activities was $2.2 million (2025), whereas its average is $1.6 million.
  • As far as peak fluctuations go, Benitec Biopharma's Other financing activities spiked by 58.59% in 2023, and later tumbled by 97.54% in 2025.
  • Quarterly analysis of 5 years shows Benitec Biopharma's Other financing activities stood at $1.6 million in 2021, then reached $1.9 million in 2022, then soared by 58.59% to $3.0 million in 2023, then reached $2,000 in 2024, then tumbled by 97.54% to $72,000 in 2025.
  • Its Other financing activities stands at $72,000 for Q2 2025, versus $2.2 million for Q1 2025 and $2,000 for Q4 2024.